Customizable mRNA Synthesis Service

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, August 2023
Volume 47
Issue 8
Pages: 12

Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.

Eurofins Genomics Blue Heron in-vitro transcription (IVT) messenger RNA (mRNA) synthesis service is designed to offer a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The synthesis service is intended for use in molecular biology, drug discovery, vaccine development, and gene therapy, among other fields.

The IVT mRNA synthesis service is designed to handle various applications and includes customizable mRNA synthesis capabilities to meet specific research needs. Researchers can customize mRNA transcripts in various ways, including modifying the sequence, length, and purity of the mRNA.

Eurofins Genomics Blue Heron

Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content